Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ADCT
#2941
ADC Therapeutics SA
3.8
9
USD
+0.26%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+0.26%
Aylık Değişim
-7.82%
6 aylık değişim
-7.82%
Yıllık Değişim
+224.17%
Önceki Kapanış
3.8
8
Open
3.9
0
Bid
Ask
Low
3.8
8
High
3.9
2
Hacim
69
Piyasalar
ABD Borsası
Sağlık Hizmetleri
ADCT
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
76.72 M
76.81 M
80.64 M
82.53 M
99.08 M
127.04 M
—
Valuation ratios
Enterprise value
2.02 B
1.09 B
-36.93 M
-14.75 M
69.31 M
304.2 M
903.57 M
Price to earnings ratio
—
—
—
-0.57
-1.23
-3.15
-8.7
Price to sales ratio
—
—
—
1.99
2.73
5.51
17
Price to cash flow ratio
—
—
—
-1.16
-1.56
-3.18
-9.86
Price to book ratio
—
—
—
-0.93
-0.95
-2.41
-3.47
Enterprise value to EBITDA ratio
-9.24
-4.14
0.29
-7.03
0.42
6.59
1.69
Profitability ratios
Return on assets %
-0.48
-0.37
-0.29
-0.68
-0.49
-0.44
-0.48
Return on equity %
-0.73
-1.38
-1.76
1.62
0.78
0.77
0.65
Return on invested capital %
—
—
—
-3 974.11
-3 028.63
-2 845.4
-7 417.58
Gross margin %
—
-4.11
-2.18
96.36
91.6
92.87
389.29
Operating margin %
—
-771.65
-58.9
-238.63
-184.44
-149.34
-624.16
EBITDA margin %
—
-772.66
-60.43
28.45
-182.46
34.91
-153.27
Net margin %
—
-678.2
-74.22
-345.11
-222.83
-175.31
-745.46
Liquidity ratios
Quick ratio
—
6.95
4.32
4.73
3.59
4.31
17.47
Current ratio
11.14
7.1
4.51
4.97
3.82
4.37
18.39
Inventory turnover
—
0.13
0.31
0.09
0.09
0.2
0.14
Asset turnover
0
0.06
0.37
0.16
0.21
0.25
0.27
Solvency ratios
Debt to assets ratio
—
—
—
0.35
0.38
0.36
1.58
Debt to equity ratio
—
—
—
-0.84
-0.61
-0.63
-2.22
Long term debt to total assets ratio
—
—
—
0.32
0.35
0.36
1.53
Long term debt to total equity ratio
—
—
—
-0.76
-0.56
-0.62
-2.16
Per share metrics
Operating cash flow per share
—
—
—
-1.45
-1.27
-1.11
-1.2
EBIT per share
—
—
—
-2.03
-1.34
-0.96
-1.02
EBITDA per share
—
—
—
0.24
-1.33
0.22
-0.35
Total debt per share
—
—
—
1.52
1.27
0.92
3.95
Cash per share
—
—
—
3.41
2.58
2.06
7.92
Net current asset value per share
—
—
—
4.12
3.16
2.41
9.72
Tangible book value per share
—
—
—
-1.81
-2.09
-1.46
-7.18
Working capital per share
—
—
—
3.29
2.34
1.86
7.61
Book value per share
—
—
—
-1.81
-2.09
-1.46
-7.18
Haberler
ADC Therapeutics, ZYNLONTA’ya odaklanıyor
H.C. Wainwright, ADC Therapeutics hisse hedefini 8 dolara yükseltti
ADC Therapeutics SA 2025 Q4 - Results - Earnings Call Presentation (NYSE:ADCT) 2026-03-11
Micron and BioNTech among market cap stock movers on Tuesday
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
Adc Thera kazancı $0,20 ile beklentilere göre daha iyi, kâr ise beklentilere göre yüksek
Adc Thera earnings beat by $0.20, revenue topped estimates
ADC Therapeutics 4Ç’te 22,3 milyon dolar gelir bildirdi
ADC Therapeutics reports Q4 revenue of $22.3 million
ADC Therapeutics %70 getiri sağladı, Gerçeğe Uygun Değer hedefine ulaşıldı
ADC Therapeutics delivers 70% return as Fair Value target hit
ADC Therapeutics TD Cowen’da: Lenfoma tedavisinde stratejik genişleme